Dr. Stanislav Beyl leads data analysis and scientific reporting at ChanPharm. He is responsible for processing and interpreting electrophysiology datasets, developing analytical pipelines, and delivering clear, publication-ready reports to clients.
More than 20 years of research on ion channels and in the field of drug discovery. Dr. Beyl's work focused on structure-function analyses (2005–2023) and the modulation of ion channels by drugs. Of particular note are his contributions to analysis of channel gating in terms of state models (Beyl et al. 2014) and the clarification of the roles of individual S4 segments in calcium channels (Beyl et al. 2016).